{
    "title": "Individual feed for https://www.2minutemedicine.com/feed/",
    "link": "https://www.2minutemedicine.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-20T07:21:53.458902",
    "items": [
        {
            "title": "Berberine is safe and effective in lowering lipoprotein cholesterol levels in metabolic dysfunction-associated steatotic liver disease",
            "link": "https://www.2minutemedicine.com/berberine-is-safe-and-effective-in-lowering-lipoprotein-cholesterol-levels-in-metabolic-dysfunction-associated-steatotic-liver-disease/",
            "description": "1. In diabetes-free individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) and obesity, berberine is safe, well-tolerated, ...",
            "pubDate": "2026-01-20T00:00:00",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2014/11/Liversteatosis_edited-300x150.png"
        },
        {
            "title": "Lyme disease is associated with significant health care costs",
            "link": "https://www.2minutemedicine.com/lyme-disease-is-associated-with-significant-health-care-costs/",
            "description": "1. Lyme disease (LD) is associated with substantial health care costs, with per-patient direct costs consistently high across several analytic methods...",
            "pubDate": "2026-01-19T16:00:47",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2016/04/18132_lores-300x150.jpg"
        },
        {
            "title": "2MM: AI Roundup – Lilly and NVIDIA’s $1B AI lab, Illumina’s Billion Cell Atlas, AstraZeneca’s Modella deal, and Claude for Healthcare [Jan 19th, 2026]",
            "link": "https://www.2minutemedicine.com/2mm-ai-roundup-lilly-and-nvidias-1b-ai-lab-illuminas-billion-cell-atlas-astrazenecas-modella-deal-and-claude-for-healthcare-jan-19th-2026/",
            "description": "NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January 2026, NVIDIA and Eli Eli ...",
            "pubDate": "2026-01-19T13:45:25",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2025/05/Untitled-design-300x170.png"
        },
        {
            "title": "2 Minute Medicine Rewind January 19, 2026",
            "link": "https://www.2minutemedicine.com/2-minute-medicine-rewind-january-19-2026/",
            "description": "Electronic Intervention for Patient-Managed Benzodiazepine Tapering 1. An electronic intervention promoting self-management of benzodiazepine cessatio...",
            "pubDate": "2026-01-19T11:00:51",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2017/05/DVT2_cc_wiki_JamesHeilmanMD_edited-300x150.jpg"
        },
        {
            "title": "Ethosuximide may not be effective for the treatment of abdominal pain in irritable bowel syndrome",
            "link": "https://www.2minutemedicine.com/ethosuximide-may-not-be-effective-for-the-treatment-of-abdominal-pain-in-irritable-bowel-syndrome/",
            "description": "1. Ethosuximide was not superior to placebo for the treatment of abdominal pain in adults with irritable bowel syndrome. Evidence Rating Level: 1 (Exc...",
            "pubDate": "2026-01-17T00:00:52",
            "image_url": "https://www.2minutemedicine.com/wp-content/uploads/2016/02/abdominalpain_PD_edited-300x150.jpg"
        }
    ]
}